-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R4eLZQilWAKwRshkj43ANB0LI5gZ5IU/jebl9ZBAdIPkZGKuiI4ekJzng22znCpy o3aAwxS3E9j+DtnYhIUfxQ== 0001187154-03-000004.txt : 20031218 0001187154-03-000004.hdr.sgml : 20031218 20031218161204 ACCESSION NUMBER: 0001187154-03-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031217 FILED AS OF DATE: 20031218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEPHALON INC CENTRAL INDEX KEY: 0000873364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232484489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 145 BRANDYWINE PKWY CITY: WEST CHESTER STATE: PA ZIP: 19380 BUSINESS PHONE: 6103440200 MAIL ADDRESS: STREET 1: 145 BRANDYWINE PARKWAY CITY: WEST CHESTER STATE: PA ZIP: 19380 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BALDINO FRANK JR CENTRAL INDEX KEY: 0001187154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19119 FILM NUMBER: 031062553 BUSINESS ADDRESS: STREET 1: 145 BRANDYWINE PARKWAY CITY: WEST CHESTER STATE: PA ZIP: 19380 BUSINESS PHONE: 6103440200 MAIL ADDRESS: STREET 1: C/O VIROPHARMA INC STREET 2: 405 EAGLEVIEW BLVD CITY: EXTON STATE: PA ZIP: 19341 4 1 edgardoc.xml PRIMARY DOCUMENT X0201 4 2003-12-17 0 0000873364 CEPHALON INC CEPH 0001187154 BALDINO FRANK JR C/O VIROPHARMA INC 405 EAGLEVIEW BLVD EXTON PA 19341 1 1 0 0 Chairman & CEO Common Stock 2003-12-17 4 A 0 85000 A 312149 D Common Stock 3545 I by Trust Incentive Stock Option (right to buy) 48.2 2003-12-17 4 A 0 150000 0 A 2007-12-17 2013-12-17 Common Stock 150000 150000 D Restricted stock award, pursuant to Company benefit plan, vesting 25% per year over 4 years. Company matching contribution to 401(k) plan. Options vest 25% on each annual anniversary of grant and are fully vested 4 years from date of grant. Options expire 10 years from date of grant. By: Carolyn S. Iosca For: Frank Baldino, Jr. 2003-12-18 -----END PRIVACY-ENHANCED MESSAGE-----